News Focus
News Focus
Followers 0
Posts 994
Boards Moderated 0
Alias Born 06/03/2015

Re: louieblouie post# 56838

Tuesday, 08/18/2015 4:01:58 PM

Tuesday, August 18, 2015 4:01:58 PM

Post# of 447325
What's clear is the FDA needs to clarify what's going on. This may take another law suit...but not updating Vascepa exclusivity and not providing any clarification is injurious to Amarin stakeholders. The if's and but's you propose are hurting my brain.

If OB doesn't update soon with exclusivity I'd be for Amarin stakeholders taking FDA to court for anticompetitive violations. The lack of exclusivity prevents business deals.

BB

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News